Forte Biosciences, Inc. 3 SEC Filings

Filed On	Filing
19 Sep 2024	Form 3: Kapoor Shivpreet Singh, Director No securities owned
19 Sep 2024	Form 3: Vincent Richard G, Director No securities owned
12 Jan 2023	Form 3: Gryska David W, Director No securities owned
14 Nov 2022	Form 3: Brun Scott C., Director No securities owned
08 Jun 2022	Form 3: Chen Hubert C, See remarks No securities owned
16 May 2022	Form 3: Doberstein Stephen K, Director No securities owned
18 Mar 2022	Form 3: Finck Barbara K, Director No securities owned
17 Jun 2020	Form 3: Walker Patricia S, Director
17 Jun 2020	Form 3: Kornfeld Steven, Director No securities owned
17 Jun 2020	Form 3: Eichenfield Lawrence, Director
17 Jun 2020	Form 3: Riley Antony A, Chief Financial Officer Holds 29,365 shares of Common Stock
17 Jun 2020	Form 3: Williams Donald Allen, Director No securities owned
17 Jun 2020	Form 3: Wagner Paul A., Director Holds 2,272,049 shares of Common Stock
28 Feb 2020	Form 3: Oliveira Steven Michael, 10% owner Holds 2,734,000 shares of Common Stock
17 Apr 2019	Form 3: Kabbinavar Fairooz, SVP Clinical Development No securities owned
12 Apr 2017	Form 3: Schimmel Paul, Director
12 Apr 2017	Form 3: Parkinson David Ross, Director
12 Apr 2017	Form 3: Kunkel Lori Anne, Director
12 Apr 2017	Form 3: Berger Franklin M, Director
12 Apr 2017	Form 3: Hasnain Faheem, Director

Comments